Journal Information
Vol. 4. Issue 2.
Pages 77-79 (March - April 2008)
Share
Share
Download PDF
More article options
Vol. 4. Issue 2.
Pages 77-79 (March - April 2008)
Clinical Cases
Full text access
Strongyloides stercolaris in a Patient With Rheumatoid Arthritis Undergoing Treatment With Etanercept
Strongyloides stercolaris en un paciente con artritis reumatoide en tratamiento con etanercept
Visits
5946
Eva Revuelta Evrard
, Paula Virginia García Morales, Adela Gallego Flores, Asunción Sánchez Trenado, Carmen Rubio Caja
Servicio de Reumatología, Hospital General de Ciudad Real, Ciudad Real, Spain
This item has received
Article information

Biologic therapy for the treatment of autoimmune diseases such as rheumatoid arthritis leads to a series of secondary effects and complications which are ever more frequent and increasingly complicate both the management as well as the associated comorbidity. We present the case of a patient who had one of theses associated complications.

Key words:
Reumatoid arthritis
Strongyloides stercolaris
Etanercept
Infection

La terapia biológica para el tratamiento de enfermedades autoinmunitarias, como la artritis reumatoide, conlleva una serie de efectos secundarios y complicaciones cada vez más frecuentes y de gran complejidad tanto en el manejo como en la comorbilidad asociada. Presentamos el caso de un paciente con una de estas complicaciones asociada.

Palabras clave:
Artritis reumatoide
Strongyloides stercolaris
Etanercept
Infección
Full text is only aviable in PDF
References
[1.]
R.S. Vadlamudi, D.S. Chi, G. Krishnaswamy.
Intestinal strongyloidiasis and hyperinfection syndrome.
Clinical and Molecular Allergy, 4 (2006), pp. 4-8
[2.]
J. Ritcher, I. Muller-Stover, H. Strothmeyer, K. Gobels, M. Schmitt, D. Haussinger.
Arthritis associated with Strongyloides stercoralis infection in a HLA B-27-positive African.
Parasitol Res, (2006),
[3.]
M.D. Boatright, B.M. Wang.
Clinical infection with Strongyloides sterocoralis following etanercept use for rheumatoid arthritis.
Arthritis Rheum, 52 (2005), pp. 1336-1337
[4.]
Early-onset polyarthritis as presenting feature of intestinal infection with Strongyloides stercoralis.
Rheumatology, 42 (2003), pp. 1419-1420
[5.]
M.A. Marchesan Rodrigex, R. Cardoso Fróes, A. Anefalos, S. Kobayasi.
Invasive enteritis by Strongyloides stercolaris presenting as acute abdominal distress under corticosteroid therapy.
Rev Hos Clin Fac, 56 (2001), pp. 103-106
[6.]
P.B. Keiser, T.B. Nutman.
Strongyloides stercoralis in the immunocompromised population.
Clin Microbiol Rev, 17 (2004), pp. 208-217
[7.]
P. Roman Sanchez, A. Pastor Guzman, S. Moreno guillen, R. Igual Adell, A. Martin Estruch, I. Navarro Gonzalo, et al.
Endemic strongyloidiasis on the Spanish Mediterranean coast.
Q J Med, 94 (2001), pp. 357-363
[8.]
M.R. Guevara, A. Rodríguez, G. Guevara.
Eficacia in vitro de los antihelmínticos: ivermectina, albendazol y tiabendazol, contra larvas filariformes de Strongyloides stercolaris, y su aplicación en el tratamiento del síndrome de hiperinfección.
Salus Militae, 26 (2001), pp. 52-55
Copyright © 2008. Sociedad Española de Reumatología and Colegio Mexicano de Reumatología
Download PDF
Idiomas
Reumatología Clínica (English Edition)
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?